Mediclinic International plc, together with its subsidiaries, operates private hospitals. More Details
Fair value with moderate growth potential.
Share Price & News
How has Mediclinic International's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MDC is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: MDC's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: MDC underperformed the UK Healthcare industry which returned 56.6% over the past year.
Return vs Market: MDC matched the UK Market which returned 18.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Mediclinic International's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StDoes This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?
1 month ago | Simply Wall StNeed To Know: Mediclinic International plc (LON:MDC) Insiders Have Been Selling Shares
3 months ago | Simply Wall StIf You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%
Is Mediclinic International undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MDC (£3.2) is trading above our estimate of fair value (£2.38)
Significantly Below Fair Value: MDC is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MDC is good value based on its PE Ratio (34.7x) compared to the UK Healthcare industry average (38.4x).
PE vs Market: MDC is poor value based on its PE Ratio (34.7x) compared to the UK market (25.6x).
Price to Earnings Growth Ratio
PEG Ratio: MDC is good value based on its PEG Ratio (0.7x)
Price to Book Ratio
PB vs Industry: MDC is good value based on its PB Ratio (0.8x) compared to the GB Healthcare industry average (2.6x).
How is Mediclinic International forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDC's forecast earnings growth (49% per year) is above the savings rate (0.9%).
Earnings vs Market: MDC's earnings (49% per year) are forecast to grow faster than the UK market (17.4% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MDC's revenue (2.6% per year) is forecast to grow slower than the UK market (5.3% per year).
High Growth Revenue: MDC's revenue (2.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDC's Return on Equity is forecast to be low in 3 years time (6.5%).
How has Mediclinic International performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDC has a large one-off gain of £23.0M impacting its March 31 2021 financial results.
Growing Profit Margin: MDC became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: MDC has become profitable over the past 5 years, growing earnings by -33.7% per year.
Accelerating Growth: MDC has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MDC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (13.3%).
Return on Equity
High ROE: MDC's Return on Equity (2.7%) is considered low.
How is Mediclinic International's financial position?
Financial Position Analysis
Short Term Liabilities: MDC's short term assets (£1.2B) exceed its short term liabilities (£684.0M).
Long Term Liabilities: MDC's short term assets (£1.2B) do not cover its long term liabilities (£3.0B).
Debt to Equity History and Analysis
Debt Level: MDC's debt to equity ratio (60%) is considered high.
Reducing Debt: MDC's debt to equity ratio has increased from 52.1% to 60% over the past 5 years.
Debt Coverage: MDC's debt is not well covered by operating cash flow (13.2%).
Interest Coverage: MDC's interest payments on its debt are well covered by EBIT (3.1x coverage).
What is Mediclinic International current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MDC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MDC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: MDC is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDC's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ronnie van der Merwe (57 yo)
Dr. Carel Aron van der Merwe, also known as Ronnie, has been Executive Director of Mediclinic International plc since June 1, 2018. Dr. van der Merwe is Group Chief Executive Officer of Mediclinic Internat...
CEO Compensation Analysis
Compensation vs Market: Ronnie's total compensation ($USD837.46K) is below average for companies of similar size in the UK market ($USD1.65M).
Compensation vs Earnings: Ronnie's compensation has been consistent with company performance over the past year.
Experienced Management: MDC's management team is considered experienced (4.8 years average tenure).
Experienced Board: MDC's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Mediclinic International plc's company bio, employee growth, exchange listings and data sources
- Name: Mediclinic International plc
- Ticker: MDC
- Exchange: LSE
- Founded: 1983
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: UK£2.358b
- Shares outstanding: 737.24m
- Website: https://www.mediclinic.com
Number of Employees
- Mediclinic International plc
- 25 Du Toit Street
- Western Cape
- South Africa
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclini...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/19 18:51|
|End of Day Share Price||2021/06/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.